Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 23 of 100
Features
Rite Aid managed to lose more than $600 million during the pandemic while its pharmacy rivals boomed. Inside the CEO’s high-stakes turnaround plan
By
Phil Wahba
June 14, 2022
Health
Peptone, a startup using A.I. to find drugs for tricky ‘disordered’ proteins, raises $40 million in venture funding
By
Jeremy Kahn
June 9, 2022
Health
New prescription drug prices soared to $180,000 a year on 20% annual inflation in 2021, study finds
By
Robert Langreth
and
Bloomberg
June 7, 2022
Health
Breast cancer drug could help more patients, researchers say: ‘It makes, for the first time, a targetable population’
By
Carla K. Johnson
and
The Associated Press
June 5, 2022
Health
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
By
Drew Armstrong
and
Bloomberg
May 25, 2022
Health
‘Pharma Bro’ Martin Shkreli has been released from federal prison early
By
Patricia Hurtado
and
Bloomberg
May 18, 2022
China ends global clinical trial of its Alzheimer’s drug
By
Bloomberg
May 13, 2022
Commentary
Companies should be guided by their purpose and values when deciding whether or not to exit Russia
By
Hubert Joly
May 12, 2022
Conferences
‘Diverse needs,’ not just ‘diverse patients’: How health care leaders can make care more equitable
By
Anne Sraders
May 11, 2022
Health
‘Please pay attention’: Scientist flagged heart-pill toxins early on
By
Anna Edney
and
Bloomberg
May 7, 2022
Commentary
The pandemic shows what patients and their doctors can contribute to research
By
Alexander Saint-Amand
April 25, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Leadership
Pfizer’s CEO pushed employees to do what they thought impossible in fast-tracking a COVID vaccine
By
Fortune Editors
April 13, 2022
Health
Investors flee COVID pill drugmaker on report tying treatment to birth defects
By
Kanoko Matsuyama
and
Bloomberg
April 13, 2022
Commentary
La Famiglia: Family values that drive business success
By
Giacomo Chiesi
April 2, 2022
Most Popular
Personal Finance
The national debt isn't $39 trillion. One economist says it's actually $100 trillion
By
Nick Lichtenberg
Success
When Jamie Dimon was fired from Citigroup, his daughters asked: 'Will we be homeless? Can I still go to college? Can I...
By
Eleanor Pringle
North America
The U.S. Mint dropped the olive branch from the dime. What does that mean for the country?
By
Catherina Gioino